Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short-term Investments (2019 - 2023)

Marimed has reported Short-term Investments over the past 10 years, most recently at $88000.0 for Q4 2023.

  • Quarterly Short-term Investments fell 28.46% to $88000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $88000.0 through Dec 2023, down 28.46% year-over-year, with the annual reading at $88000.0 for FY2023, 28.46% down from the prior year.
  • Short-term Investments was $88000.0 for Q4 2023 at Marimed, down from $161000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $1.4 million in Q4 2019 and troughed at $88000.0 in Q4 2023.
  • The 5-year median for Short-term Investments is $643571.0 (2020), against an average of $655710.1.
  • Year-over-year, Short-term Investments skyrocketed 72.15% in 2021 and then crashed 91.7% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $1.4 million in 2019, then fell by 6.35% to $1.4 million in 2020, then tumbled by 81.51% to $251000.0 in 2021, then crashed by 51.0% to $123000.0 in 2022, then dropped by 28.46% to $88000.0 in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Short-term Investments are $88000.0 (Q4 2023), $161000.0 (Q3 2023), and $102000.0 (Q2 2023).